Apr 28, 2022 / 11:00AM GMT
Operator
Ladies and gentlemen, welcome to the Immunovia Q1 Interim Report 2022 Conference Call. I'm Alice, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Tobias Bülow, Senior Director, Investor Relations and Corporate Communications. Please go ahead, sir.
Tobias Bülow - Immunovia AB(publ)-Senior Director of IR&Corporate Communications
Thank you. Good morning, and a warm welcome to Immunovia's First Quarter 2022. My name is Tobias Bülow, and I'm heading Investor Relations. With me today here in Lund in Sweden, I have the Immunovia President and CEO, Philipp Mathieu; and our CFO, Karin Almqvist Liwendahl. I also have the pleasure to inform you that we have our new U.S. CEO, Jeff Borcherding with us as well today.
(Operator Instructions) We will end at latest 2:00. And for your information, this session will also be
Q1 2022 Immunovia AB (publ) Earnings Call Transcript
Apr 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers